HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.

Abstract
Tumor hypoxia is a well known therapeutic problem which contributes to radioresistance and aggressive tumor characteristics. Lack of techniques for repeated measurements of tumor oxygenation (pO(2), partial pressure of oxygen) has restricted the optimization of hypoxia modifying methods and their efficacious application with radiotherapy. We have investigated a non-invasive method to enhance tissue pO(2) of peripheral tumors using topical application of formulations with BN (Benzyl Nicotinate), a vasodilator, and have used EPR (Electron Paramagnetic Resonance) oximetry to follow its effect on tumor oxygenation.We incorporated 2.5% BN in both hydrogel and microemulsions and investigated the effects on pO(2) of subcutaneous RIF-1 (Radiation Induced Fibrosarcoma) tumors in C3H mice. The experiments were repeated for five consecutive days. The topical application of BN in hydrogel led to a significant increase from a pre-treatment pO(2) of 9.3 mmHg to 11 - 16 mmHg at 30 - 50 min on day 1. However, the magnitude and the time of significant increase in pO(2) decreased with repeated topical applications. The BN in a microemulsion resulted in a significant increase from a baseline pO(2) of 8.8 mmHg to 13 - 18 mmHg at 10 - 50 min on day 1. Experiments repeated on subsequent days showed a decline in the magnitude of pO(2) increase on repeated applications. No significant change in tumor pO(2) was observed in experiments with formulations without BN (vehicle only).EPR oximetry was successfully used to follow the temporal changes in tumor pO(2) during repeated applications for five consecutive days. This approach can be potentially used to enhance radiotherapeutic outcome by scheduling radiation doses when an increase in tumor pO(2) is observed after topical applications of BN formulations.
AuthorsZrinka Abramovic, Huagang Hou, Kristl Julijana, Marjeta Sentjurc, Jean P Lariviere, Harold M Swartz, Nadeem Khan
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 701 Pg. 75-82 ( 2011) ISSN: 0065-2598 [Print] United States
PMID21445772 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Nicotinic Acids
  • Radiation-Sensitizing Agents
  • Vasodilator Agents
  • nicotinic acid benzyl ester
  • Oxygen
Topics
  • Administration, Topical
  • Animals
  • Electron Spin Resonance Spectroscopy
  • Female
  • Fibrosarcoma (radiotherapy)
  • Hypoxia
  • Mice
  • Mice, Inbred C3H
  • Neoplasms, Radiation-Induced (radiotherapy)
  • Nicotinic Acids (administration & dosage, pharmacology)
  • Oximetry
  • Oxygen (metabolism)
  • Radiation-Sensitizing Agents (administration & dosage, pharmacology)
  • Sarcoma, Experimental (radiotherapy)
  • Vasodilator Agents (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: